GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Treasury Stock

Incanthera (AQSE:INC) Treasury Stock : £0.00 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Incanthera's treasury stock for the quarter that ended in Sep. 2023 was £0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Incanthera Treasury Stock Historical Data

The historical data trend for Incanthera's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Treasury Stock Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Treasury Stock
- - - -

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Treasury Stock Get a 7-Day Free Trial - - - - -

Incanthera Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Incanthera (AQSE:INC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Treasury Stock
Comparable Companies
LSE:GENF LSE:EVG LSE:APTA LSE:FAB LSE:IXI LSE:RENE LSE:CIZ LSE:OCTP LSE:IMM LSE:NFX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Website
http://www.incanthera.com
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines